Helen Milton

Keine laufenden Positionen mehr

Health Technology

Consumer Services

Profil

Helen Milton formerly worked at Keryx Biopharmaceuticals, Inc., as Vice President-Global Regulatory Affairs & Quality from 2014 to 2017, AMAG Pharmaceuticals, Inc., as Senior VP-Regulatory Affairs & Quality in 2020, Mallinckrodt Pharmaceuticals, as Senior VP-Regulatory Affairs & Pharmacovigilance from 2021 to 2022, and Viridian Therapeutics, Inc., as Senior Vice President-Regulatory Affairs from 2023 to 2024.
Dr. Milton received her undergraduate degree and doctorate degree from The University of Liverpool.

Ehemalige bekannte Positionen von Helen Milton

Unternehmen	Position	Ende
VIRIDIAN THERAPEUTICS, INC.	General Counsel	02.01.2024
AMAG PHARMACEUTICALS, INC.	General Counsel	01.12.2020
KERYX BIOPHARMACEUTICALS	General Counsel	01.05.2017

Sehen Sie sich die Erfahrung von Helen Milton im Detail an

Ausbildung von Helen Milton

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Helen Milton im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	4
Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease	Health Technology
The University of Liverpool The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Viridian Therapeutics, Inc. Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products	Health Technology